BioBasque, the Basque Region

Legal Terms of Use

Website Information

The Basque Bioregion

• What is BioBasque

• The history: a strategic bid

• The organisation behind

• A prosperous region

The Bioindustry

• More than 70 life sciences companies

• Company directory and map

  • Company directory

• Business environment

Science and Research

• The science and technology community

• Healthcare system

• Technology platforms

• Networks

  • List of RETICs

Innovation System

• Business incubation centres

• Technology Parks

• Venture capital and Investors

• Talent attraction

Bioregion Directory

News

• A Basque consortium develops a technology to diagnose child neurodevelopment disorders

• A Basque researcher identifies a possible alternative to biopsy in diagnosing celiac disease

• A Biolan biosensor measures the quality of grapes from the latest harvest in France, Spain and Portugal

• A delegation from Aquitaine visits the Basque Bioregion

• A genetics study confirms that Basque people are a homogeneous group distinguishable from other European populations

• A lab on a chip

• A North American biocompany is to market a CIC bioGUNE anti-cancer drug development product

• A study of the University of the Basque Country reveals that cannabis consumption increases appetite

• A&B and Guserbiot develop a biological ingredient against foodborne diseases

• A&B Laboratorios de Biotecnología receives award for good environmental business practic

• A&B Laboratorios de Biotecnología, finalist in the European Business Award for the Environment

• AJL Ophthalmic invests 5M€ in new plant at the Alava Technology Park

• At Bio San Diego 2008, DRO Biosystems presents a revolutionary system to grow therapeutic cells

• Autism project reveals genetics as main cause of this illness

• Basque biocompanies improve their international contacts at BIO Atlanta 2009

• Basque biocompany Vacunek develops kit for detecting the new flu virus

• Basque Health Department and Mondragon Corporation to cooperate

• Basque researcher part of team to discover three new genes involved in mental disability

• Bial sets up in Italy through the acquisition of firm specialised in allergic immunotherapy

• Bial takes part in European project for development of two biotechnological vaccines against severe food allergies

• BIC Gipuzkoa Berrilan wins the Science Alliance award for its capability to nurture new enterprises

• BioBasque launches its new Newsletter

• Biobide and AZTI –Tecnalia, in the DareNET Platform to promote the use of the zebrafish animal model

• Biobide and Pharmakine sign a business cooperation agreement

• Biobide is one of the speakers at the DIA Annual Meeting held in San Diego (USA)

• Biobide, invited speaker at the World Pharmaceutical Congress in Philadelphia (USA)

• Biobide, one of the four prizewinning companies in the Bio Buzz competition organised by Bio Atlanta 2009

• Biobide’s major scientific advances at the 7th Annual Screening Europe

• Biocompanies and research on the rise in the Bizkaia Technology Park

• BioDonostia and CIDETEC-IK4 sign a collaboration agreement

• BioDonostia evaluates the use of a food-related method for the diagnosis of hepatic steatosis

• Bioftalmik patents new non-invasive diagnosis system for eye disease

• Bioftalmik present at ARVO 2010 Annual Meeting

• Biolan reaches an agreement to market biosensors for viticultural use in Argentina

• BTI authored the third worldwide clinical trial on the use of antibiotics in oral implantology

• BTI takes part in international conference at U.S. Hopkins Biotech Network

• Cancer sufferers will be able to consult their doctors through the Osakidetza website

• CEIT, Tecnun and Berkeley promote an MSc in Biomedical Engineering

• Chips to detect whether a patient is genetically predisposed to high cholesterol

• CIC bioGUNE and Columbia University conduct joint research into a metabolic enzyme that causes genetic diseases

• CIC bioGUNE and Proteomika create largest catalogue of proteins from endometrial fluid

• CIC bioGUNE and the Biophysics Unit at the UPV/EHU to perform research at the ESRF in Grenoble

• CIC bioGUNE brings international experts together at a workshop on Structural Virology

• CIC bioGUNE in the European systems genetics network - SYSGENET

• CIC bioGUNE opens new lab for prion disease research

• CIC bioGUNE research scientists identify risk gene affecting liver regeneration

• CIC bioGUNE researchers discover a connection between Alzheimer's and prion diseases

• CIC bioGUNE researchers discover a new way to research liver cancer

• CIC bioGUNE researchers discover why some proteins are resistant to salt

• CIC bioGUNE´s Structural Biology Unit, on ETB.

• CIC bioGUNE’s first lustrum closes with 120 scientific papers, 9 registered patents and 4 new companies

• CIC bioGUNE’s researchers hit on a mechanism explaining cancer-related DNA mutations

• CIC bioGUNE's researchers show a way to control prion disease epidemics in deer

• CIC bioGUNE's technology used at Harvard University and the Pasteur Institute

• CIC biomaGUNE applies for two new European patents on atomic force microscopy

• CIC biomaGUNE gets ready for the start-up of the most powerful Molecular Imaging Unit in Spain

• CIC biomaGUNE is to take part in an international project to develop anti-retroviral microbicides against HIV

• CIC biomaGUNE seeks new image diagnosis for cardiovascular diseases

• CIC biomaGUNE to lead a European project to test the toxicity of metal oxide nanoparticles

• CIC biomaGUNE, CIC nanoGUNE and DIPC take part in a European project developing a novel nanobiosensor to diagnose diseases

• CIC biomaGUNE´s new Molecular Imaging Unit, on ETB

• CIC biomaGUNE’s researchers develop a new diagnostic method based on quantum dots

• CIC biomaGUNE’s researchers develop breast cancer diagnostic method

• CIC microGUNE and BioDonostia are cooperating to apply research in fast diagnosis to the clinical setting

• CIC microGUNE develops a cocaine detection patch

• Cruces Hospital and Mondragon University are collaborating on three research projects

• Cruces Hospital, Gaiker and Ikerlan develop a new portable diagnostic tool for patients with colorectal cancer

• Donostia Hospital co-authors a paper on dementia in Nature Genetics

• Donostia Hospital discovers early diagnosis method for multiple sclerosis

• Dr. María dM Vivanco, a CIC bioGUNE researcher, is given an award by the Spanish Foundation for Senology and Mammary Pathology

• DRO Biosystems and Biomedal renew the agreement for the use of the Cascade protein expression system

• DRO BIOSYSTEMS is collaborating with 3P Biopharmaceuticals in the fight against viral and tumoral diseases

• DRO Biosystems is developing a system capable of recreating the natural environment for cell growth

• Dynakin to operate in over 40 countries after signing with German company nDr. Regenold

• Eduardo Anitua and Mikel Sanchez attend an IOC meeting to agree on the use of platelet-rich plasma in sports

• Eleven Basque companies will take part in the most important convention in the world in conjunction with the BioBasque Agency

• Embryomics Scientific Chief Officer awarded first prize for innovation in the treatment of assisted reproduction

• Faes Farma and Pharmakine involved in Oncologica to fight cancer

• Faes Farma licenses Pierre Fabre to market Bilastine in France and Belgium

• Faes Farma records €21M profit and issues €1.5M secondary offering

• Faes Farma recovers Flufenoxina licence and continues international marketing of Bilastina

• Faes Farma signs a licensing agreement with Pfizer to market Bilastina in Mexico

• Faes Farma signs a strategic alliance with Cinfa to market its generic products in Portugal

• Faes Farma signs an agreement with SLA Pharma to market a drug to treat Crohn's disease

• Faes Farma wins exclusive agreement with Merck Sharp & Dohme to market anti-inflammatory drug in Spain

• Felix Goñi appointed President of the Biophysical Society’s International Relations Committee

• Galdakao Hospital and UPV/EHU, award winners at the “European Congress of Radiology 2010”

• Genetadi Biotech inaugurates new premises and expands its diagnostics and genetic analysis business

• Guserbiot develops the first indigenous yeast for Rioja Alavesa wines

• Histocell and Ferrer Grupo to develop new cell therapy drug

• Histocell reels in 3 million euros in investments from new and existing investors

• Histocell wins the 21st Enterprise Prize for the Basque Country

• Histocell, Abiatu 10th Anniversary Special Prize to the best TBC from the University of the Basque Country

• Hospital Donostia is taking part in an international clinical trial against Alzheimer’s

• IDOKI presents new SCF-derived products

• IK4 is leading three European FP7 projects with bioscience applications

• IK4's STD detection device to be marketed in India

• Ikerchem is developing molecules to inhibit cancer cell growth

• IkerChem obtains the Expoquimia R&D&I Award in the biotechnology projects category

• IkerChem wins the Basque Entrepreneur XXI award

• Ikerchem wins the Emprendedor XXI award

• Inbiomed joins the National Stem Cell Bank

• Inkoa and Cidetec-IK4 develop a device for detecting pesticides in water for human consumption

• Innoprot develops new drug test for Alzheimer’s

• Innoprot wins the Gaztedi Prize for young entrepreneurs

• Inteman Laboratorios launches three new maintenance products

• International experts are to study the latest breakthroughs in genetic research into cancer in Bilbao

• José Elguero lectures on Nuclear Magnetic Resonance on the first anniversary of CIC biomaGUNE

• KB Data Mining signs a distribution agreement with Danish firm CLC bio for the Spanish market

• Likuid Nanotek places 2M€ in new production plant

• Management bodies for clinical and health research in hospitals have been brought together in the Basque Country by BIOEF

• Midatech Group is to develop new drugs at its Bizkaia plant after signing an agreement with MonoSol Rx

• Mikel Valle, a CIC bioGUNE researcher, wins the 2009 EBSA Prize

• Mungivet develops a system to diagnose ruminant diseases that might spread to humans

• Neiker-Tecnalia finds a biopolymer substitutive to growth-promoting antibiotics for ruminants

• Neurogenomiks UPV/EHU is leading a European research project on multiple sclerosis and brings international experts

• New facilities and a new appointment consolidate the growth of OWL Genomics

• Noray BG presents the first “LIMS” specifically for the Spanish biotechnology sector at BioSpain 2008

• NorayBio is collaborating with Puleva on an ambitious research project against obesity

• NorayBio presents a new version of its software, used to predict the effect of new medicaments, in Vienna

• NorayBio, the biotechnological company, consolidates its internationalisation process with two new commercial agreements

• Ophthalmic Biology Group from Basque University and University of Pennsylvania step up collaboration

• OWL Genomics new headquarters opening ceremony in the Technology Park of Bizkaia

• OWL Genomics receives Basque Government certification as a diagnostic laboratory

• Owl Genomics strengthens its capital and promotes pioneer "cash out" operations in bioindustry

• Pharmakine takes part in the 12th Congress of the Spanish Association for Cancer Research

• Pharmakine, a biotechnological company that researches cancer and its metastasis, holds the first meeting of its new scientific

• Professor Rodriguez Arrondo, from the University of the Basque Country, awarded by the Spanish Biophysical Society

• Progenika continues international expansion, in Kuwait

• Progenika launches two new products to avoid diseases in newborns, pregnant women and cancer patients

• Progenika opens new development centre in Bizkaia with €8M investment

• Progenika set to grow in the US with million-dollar investment by COFIDES

• Progenika signs a contract with the American ARUP laboratories to provide blood analysis services

• Progenika to develop Companion Dx for AMT gene therapy

• Progenika wins the innovation award at the Basque Enterprise Encounter

• Proteomika and CIC bioGUNE investigate biomarkers for arthrosis diagnosis

• Proteomika and Donostia Hospital launch chip to detect pneumonia and other infections

• Proteomika improves follow-up of chronic inflammatory illnesses such as arthritis or Crohn’s disease

• Recently created biocompany Embryomics developing a new technique for the study of embryos

• Renal Foundation acquires shares in OWL Genomics through MDRenal stock swap

• Research at the Santiago Hospital in Vitoria reveals brain damage from cannabis is reversible

• Research team led by CIC bioGUNE discovers a mechanism for regulating a protein that inhibits fungal growth

• Researchers at CIC bioGUNE reveal evolution of prehistoric protein in the human body

• Researchers from Basque university and hospitals identify new melanoma tumour markers

• Researchers from BTI and UPV/EHU analyse the latest biomedical progress for brain regeneration in ‘Nature Reviews Neuroscience’

• Researchers from CIC bioGUNE develop a bioinformatics application that helps to interpret microRNAs

• Researchers from CIDETEC-IK4, the CSIC and the University of Berkeley develop a nanosensor to detect diseases

• Researchers from the the UPV/EHU present two projects to improve the quality of Rioja Alavesa wines

• Researchers from the University of the Basque Country find new path for novel Alzheimer’s therapies

• Researchers from the UPV/EHU and Ciber-BBN receive national recognition from the Spanish Association for Pharmaceutical Law

• Researchers from UPV/EHU and MIT(USA) discover an alloy that enables the creation more sensitive micro-devices for biomedicine

• Santiago Apostol Hospital, first prize for research into early phases in mental illnesses

• The Basque biocompany Histocell visits the United Arab Emirates in search of new opportunities

• The Basque Bioregion boosts its international projection by participating in the BioSpain 2008 forum

• The Basque biotechnology company Progenika sets up in the United Arab Emirates

• The Basque biotechnology firm Histocell is collaborating with NEURON BPh in the search for drugs to fight Alzheimer’s disease

• The Basque Country is promoting the creation of the new State Bioregions Network (RBR)

• The Basque Country to be represented by the BioBasque Agency at the world’s leading biotechnology congress

• The Basque Public Health Service was involved in 480 projects in medical and health research during 2008

• The Belgian region of Wallonia declares the Basque Country a priority market in biotechnology

• The BIO Foundation presents the Basque Research BioBank, O+Ehun

• The BioBasque Agency meets the Biotechnology Industry Organization (BIO) in Atlanta

• The BioDonostia Institute is a new flagship research centre

• The Bizkaia Biophysics Foundation leads an international project on Chagas disease

• The Cruces Hospital coordinates a study on the prevalence of diabetes

• The Eduardo Anitua Foundation for biomedical research is born

• The Eduardo Anitua Foundation organises the International Symposium on Translational Regenerative Medicine, in Vitoria-Gasteiz

• The Inter-University Chair in Law and the Human Genome publishes a report on ethical controls in biomedicine

• The PRGF technology conceived by BTI opens up its scope of applications to dermatology

• The Progenika Group holds the official opening of its US facilities

• The Progenika LIPOchip receives the recognition of the XV International Symposium on Atherosclerosis held in Boston (U.S.A.)

• The University of the Basque Country (UPV-EHU) hosts the 31st Congress of the Spanish Society for Biochemistry and Molecular Bi

• The University of the Basque Country incorporates a Biotechnology Degree for next academic year

• Thirty Basque businesses and organisations in the world’s leading Biotechnology Conference

• Three new genes linked to Alzheimer’s identified

• Two researchers from Cruces Hospital awarded prizes for describing new paediatric syndrome

• Txagorritxu Hospital opens first hospital-based brain bank in the Basque Country

• UPV/EHU organises a conference linking cannabis and schizophrenia

• UPV/EHU Professor Javier Meana, recipient of Best Spanish Researcher in Psychiatry Award

• UPV/EHU research on the "Prestige", one of the most cited on marine pollution

• UPV/EHU’s research in Microbiology front cover

• UPV/EHU’s research in the top 20 of the Journal of the American Chemical Society

• Vacunek launches new kit to detect pathogens causing bovine mastitis

• Vacunek markets a new fast milk diagnosis method to control bovine mastitis

• Very positive outcome for the Basque BioRegion in BIO 2010

• Vita Aidelos moves to Bizkaia Technology Park and expands sales throughout Europe

• Vita Aidelos organises a scientific communication competition together with the Ministry of Science and Innovation

• Ysios participates in Biovex’s $70M final closing

• A CIC bioGUNE team unveils new findings about the structure of protein p53

• A great turn-out at BTI´s 6th international oral implantology symposium

• AJL Ophthalmic, Bioftalmik, Biolan, BTI, Faes Farma, Progenika, CIC bioGUNE and Inasmet-Tecnalia, in the major ophthalmology Spanish research project

• Award to Proteomika for its project on identification of biomarkers for clinical diagnoses

• Biolan develops a biosensor capable of detecting a harmful acid that affects wine quality

• CIC bioGUNE allows the best Spanish researchers of hepatic and digestive diseases the use of its technological platforms

• CIC bioGUNE fosters the creation of mixed research units together with three Basque bio-firms

• Mertxe de Renobales of the UPV/EHU awarded prize for work on genetically modified crops by the International Society of Bioethics

• Noray Biosciences Group: a new contributor to the Spanish biotechnology sector

• Patenta: a new industrial property agency

• Progenika presents revolution in transfusion safety to american associations of blood banks

• The Basque Country hosts the 3rd General Assembly of the SmartHEALTH European project

• The University of the Basque Country and Cruces Hospital win an award for their work with newborns

• News repository

  • 2009

• Newsletter

Events

• August 2010

• September 2010

• October 2010

• Novemer 2010

• February 2010

• April 2010

• May 2010

• June 2010

• June 2008

• September 2008

• October 2008

• July 2008

• November 2008

• December 2009

• January 2010

• March 2010

• July 2010

• December 2008

• January 2009

• February 2009

• March 2009

• April 2009

• May 2009

• June 2009

  • copia

• July 2009

• October 2009

• September 2009

• August 2009

• November 2009

• November 2007

• December 2007

• January 2008

• February 2008

• March 2008

• April 2008

• May 2008

Links

Contact us

Newsletter

• Subscription to BioBasque Newsletter